Annual report

Period2021-04-01 → 2022-03-31
Filed2022-06-28
StandardJapan GAAP
ConsolidatedNo
Data checks13 of 13 passed
Key figures · 78
MetricValuePeriodScopeSource row
Revenue¥264m2021-04-01 → 2022-03-31StandaloneNet sales
Revenue¥313m2020-04-01 → 2021-03-31StandaloneNet sales
Revenue¥553m2019-04-01 → 2020-03-31dStandaloneNet sales (5-year summary)
Revenue¥497m2018-04-01 → 2019-03-31dStandaloneNet sales (5-year summary)
Revenue¥259m2017-04-01 → 2018-03-31dStandaloneNet sales (5-year summary)
Operating income−¥2.1bn2021-04-01 → 2022-03-31StandaloneOperating income
Operating income−¥1.3bn2020-04-01 → 2021-03-31StandaloneOperating income
Ordinary income−¥1.9bn2021-04-01 → 2022-03-31StandaloneOrdinary income
Ordinary income−¥1.3bn2020-04-01 → 2021-03-31StandaloneOrdinary income
Ordinary income−¥1.1bn2019-04-01 → 2020-03-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income−¥1.8bn2018-04-01 → 2019-03-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income−¥5.3bn2017-04-01 → 2018-03-31dStandaloneOrdinary income loss (5-year summary)
Profit before tax−¥1.9bn2021-04-01 → 2022-03-31StandaloneIncome before income taxes
Profit before tax−¥2.8bn2020-04-01 → 2021-03-31StandaloneIncome before income taxes
Net income−¥1.9bn2021-04-01 → 2022-03-31StandaloneProfit loss
Net income−¥2.8bn2020-04-01 → 2021-03-31StandaloneProfit loss
Net income−¥2.0bn2019-04-01 → 2020-03-31dStandaloneNet income loss (5-year summary)
Net income−¥1.8bn2018-04-01 → 2019-03-31dStandaloneNet income loss (5-year summary)
Net income−¥5.4bn2017-04-01 → 2018-03-31dStandaloneNet income loss (5-year summary)
Total assets¥7.1bnat 2022-03-31StandaloneAssets
Total assets¥7.8bnat 2021-03-31StandaloneAssets
Total assets¥8.9bnat 2020-03-31dStandaloneTotal assets (5-year summary)
Total assets¥8.6bnat 2019-03-31dStandaloneTotal assets (5-year summary)
Total assets¥7.6bnat 2018-03-31dStandaloneTotal assets (5-year summary)
Total liabilities¥1.6bnat 2022-03-31StandaloneLiabilities
Total liabilities¥321mat 2021-03-31StandaloneLiabilities
Net assets / equity¥5.6bnat 2022-03-31StandaloneNet assets
Net assets / equity¥7.5bnat 2021-03-31StandaloneNet assets
Net assets / equity¥8.8bnat 2020-03-31dStandaloneNet assets
Net assets / equity¥5.9bnat 2019-03-31dStandaloneNet assets (5-year summary)
Net assets / equity¥4.7bnat 2018-03-31dStandaloneNet assets (5-year summary)
Cash and deposits¥3.5bnat 2022-03-31StandaloneCash and deposits
Cash and deposits¥3.9bnat 2021-03-31StandaloneCash and deposits
Cash & equivalents¥1.1bnat 2022-03-31StandaloneCash and cash equivalents
Cash & equivalents¥1.9bnat 2021-03-31StandaloneCash and cash equivalents
Cash & equivalents¥4.0bnat 2020-03-31dStandaloneCash and cash equivalents
Cash & equivalents¥3.1bnat 2019-03-31dStandaloneCash and cash equivalents (5-year summary)
Cash & equivalents¥2.7bnat 2018-03-31dStandaloneCash and cash equivalents (5-year summary)
Operating cash flow−¥1.8bn2021-04-01 → 2022-03-31StandaloneNet cash provided by used in operating activities
Operating cash flow−¥1.2bn2020-04-01 → 2021-03-31StandaloneNet cash provided by used in operating activities
Operating cash flow−¥1.1bn2019-04-01 → 2020-03-31dStandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow−¥2.0bn2018-04-01 → 2019-03-31dStandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow−¥4.9bn2017-04-01 → 2018-03-31dStandaloneNet cash provided by used in operating activities (5-year summary)
Investing cash flow−¥244m2021-04-01 → 2022-03-31StandaloneNet cash provided by used in investment activities
Investing cash flow−¥872m2020-04-01 → 2021-03-31StandaloneNet cash provided by used in investment activities
Investing cash flow−¥112m2019-04-01 → 2020-03-31dStandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow−¥992m2018-04-01 → 2019-03-31dStandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow¥215m2017-04-01 → 2018-03-31dStandaloneNet cash provided by used in investing activities (5-year summary)
Financing cash flow¥1.1bn2021-04-01 → 2022-03-31StandaloneNet cash provided by used in financing activities
Financing cash flow−¥11m2020-04-01 → 2021-03-31StandaloneNet cash provided by used in financing activities
Financing cash flow¥2.2bn2019-04-01 → 2020-03-31dStandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow¥3.4bn2018-04-01 → 2019-03-31dStandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow¥24m2017-04-01 → 2018-03-31dStandaloneNet cash provided by used in financing activities (5-year summary)
EPS (basic)¥-26.92021-04-01 → 2022-03-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-41.532020-04-01 → 2021-03-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-32.682019-04-01 → 2020-03-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-39.142018-04-01 → 2019-03-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-125.392017-04-01 → 2018-03-31dStandaloneBasic earnings loss per share (5-year summary)
Net assets per share¥79.08at 2022-03-31StandaloneNet assets per share (5-year summary)
Net assets per share¥106.13at 2021-03-31StandaloneNet assets per share (5-year summary)
Net assets per share¥131.33at 2020-03-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥117.22at 2019-03-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥103.38at 2018-03-31dStandaloneNet assets per share (5-year summary)
Equity ratio77.6%at 2022-03-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio94.8%at 2021-03-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio97.0%at 2020-03-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio67.6%at 2019-03-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio58.6%at 2018-03-31dStandaloneEquity to asset ratio (5-year summary)
Shares issued70,011,258at 2022-03-31StandaloneTotal number of issued shares (5-year summary)
Shares issued69,882,158at 2021-03-31StandaloneTotal number of issued shares (5-year summary)
Shares issued66,057,401at 2020-03-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued49,402,584at 2019-03-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued43,236,584at 2018-03-31dStandaloneTotal number of issued shares (5-year summary)
Employees24at 2022-03-31StandaloneNumber of employees
Employees27at 2021-03-31StandaloneNumber of employees
Employees29at 2020-03-31dStandaloneNumber of employees
Employees42at 2019-03-31dStandaloneNumber of employees
Employees51at 2018-03-31dStandaloneNumber of employees

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

All source rows · 904
ItemContextValueUnit
Significant accounting estimates financial statements (text)CurrentYearDurationText · Plus
Notes changes in accounting policies in accordance with changes in accounting standards etc financial statements (text)CurrentYearDurationText · Plus
Notes new accounting standards not yet applied financial statements (text)CurrentYearDurationText · Plus
Notes changes in presentation financial statements (text)CurrentYearDurationText · Plus
Notes additional information financial statements (text)CurrentYearDurationText · Plus
Notes regarding presentation of accumulated impairment loss (text)CurrentYearInstant_NonConsolidatedMemberText · Plus
Notes regarding amount of revenue from contracts with customers (text)CurrentYearDuration_NonConsolidatedMemberText · Plus
Major components of selling general and administrative expenses (text)CurrentYearDuration_NonConsolidatedMemberText · Plus
Research and development expenses included in general and administrative expenses and manufacturing cost for current period (text)CurrentYearDuration_NonConsolidatedMemberText · Plus
Notes regarding loss on disposal and sales of property plant and equipment (text)CurrentYearDuration_NonConsolidatedMemberText · Plus
Notes regarding impairment loss (text)CurrentYearDuration_NonConsolidatedMemberText · Plus
Notes regarding issued shares and treasury shares (text)Prior1YearDuration_NonConsolidatedMemberText · Plus
Notes regarding new share subscription rights etc (text)Prior1YearDuration_NonConsolidatedMemberText · Plus
Notes regarding dividend (text)Prior1YearDuration_NonConsolidatedMemberText · Plus
Notes regarding issued shares and treasury shares (text)CurrentYearDuration_NonConsolidatedMemberText · Plus
Notes regarding new share subscription rights etc (text)CurrentYearDuration_NonConsolidatedMemberText · Plus
Notes regarding dividend (text)CurrentYearDuration_NonConsolidatedMemberText · Plus
Reconciliation of ending balance of cash and cash equivalents with account balances per balance sheet (text)CurrentYearDuration_NonConsolidatedMemberText · Plus
Major components of assets and liabilities increased or decreased as result of acquisition or disposal of business or merger etc whereby cash was paid or received as consideration (text)CurrentYearDuration_NonConsolidatedMemberText · Plus
Notes financial instruments financial statements (text)CurrentYearDurationText · Plus
Notes securities financial statements (text)CurrentYearDurationText · Plus
Notes derivatives financial statements (text)CurrentYearDurationText · Plus
Notes retirement benefits financial statements (text)CurrentYearDurationText · Plus
Notes share options etc financial statements (text)CurrentYearDurationText · Plus
Notes tax effect accounting financial statements (text)CurrentYearDurationText · Plus
Notes asset retirement obligations financial statements (text)CurrentYearDurationText · Plus
Notes business combinations financial statements (text)CurrentYearDurationText · Plus
Notes revenue recognition financial statements (text)CurrentYearDurationText · Plus
Notes segment information etc financial statements (text)CurrentYearDurationText · Plus
Description of fact that companys business comprises single segmentCurrentYearDuration_NonConsolidatedMember
Original text (Japanese)当社の事業は、医薬品等の研究開発及び製造販売並びにこれらの付随業務の単一セグメントであるため、記載は省略しております。
Information for each product or service (text)Prior1YearDuration_NonConsolidatedMemberText · Plus
Revenues from external customers information for each region (text)Prior1YearDuration_NonConsolidatedMemberText · Plus
Property plant and equipment information for each region (text)Prior1YearDuration_NonConsolidatedMemberText · Plus
Information for each of main customers (text)Prior1YearDuration_NonConsolidatedMemberText · Plus
Information for each product or service (text)CurrentYearDuration_NonConsolidatedMemberText · Plus
Revenues from external customers information for each region (text)CurrentYearDuration_NonConsolidatedMemberText · Plus
Property plant and equipment information for each region (text)CurrentYearDuration_NonConsolidatedMemberText · Plus
Information for each of main customers (text)CurrentYearDuration_NonConsolidatedMemberText · Plus
Notes equity in earnings losses of affiliates if equity method is applied financial statements (text)CurrentYearDurationText · Plus
Notes related parties financial statements (text)CurrentYearDurationText · Plus
Notes per share information financial statements (text)CurrentYearDurationText · Plus
Notes significant events after reporting period financial statements (text)CurrentYearDurationText · Plus
Annexed detailed schedule of securities (text)CurrentYearDurationText · Plus
Annexed detailed schedule of property plant and equipment etc (text)CurrentYearDurationText · Plus
Annexed detailed schedule of corporate bonds financial statements (text)CurrentYearDurationText · Plus
Annexed detailed schedule of borrowings financial statements (text)CurrentYearDurationText · Plus
Annexed detailed schedule of provisions (text)CurrentYearDurationText · Plus
Annexed detailed schedule of asset retirement obligations financial statements (text)CurrentYearDurationText · Plus
Components of major assets and liabilities (text)CurrentYearDurationText · Plus
Other information financial statements etc (text)CurrentYearDurationText · Plus

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 13 of 13 passed
balance sheet identitynon_consolidated 2021-03-31pass
balance sheet identitynon_consolidated 2022-03-31pass
dei present pass
period resolution pass
statement vs summary · net assetsnon_consolidated 2020-03-31pass
statement vs summary · net assetsnon_consolidated 2021-03-31pass
statement vs summary · net assetsnon_consolidated 2022-03-31pass
statement vs summary · operating cash flownon_consolidated 2020-04-01/2021-03-31pass
statement vs summary · operating cash flownon_consolidated 2021-04-01/2022-03-31pass
statement vs summary · revenuenon_consolidated 2020-04-01/2021-03-31pass
statement vs summary · revenuenon_consolidated 2021-04-01/2022-03-31pass
statement vs summary · total assetsnon_consolidated 2021-03-31pass
statement vs summary · total assetsnon_consolidated 2022-03-31pass